美沙拉嗪-话题@MedSci

#美沙拉嗪#

7篇内容 | 600人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2189402, encodeId=a6b62189402b5, content=<a href='/topic/show?id=16736249246' target=_blank style='color:#2F92EE;'>#梭菌#</a> <a href='/topic/show?id=a8e511155653' target=_blank style='color:#2F92EE;'>#山梨醇#</a> <a href='/topic/show?id=5d7211155e1f' target=_blank style='color:#2F92EE;'>#粪厌氧棒杆菌#</a> <a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Cell：新研究对山梨醇不耐受症的病因和治疗提出新的见解, objectType=article, longId=814032, objectId=753681403224, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240221/1708470729986_2185383.png, objectUrl=/article/show_article.do?id=753681403224, replyNumber=0, likeNumber=11, createdTime=2024-02-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1702863, encodeId=adb61e0286318, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Clin Gastroenterology H：在克罗恩病患者中停止美沙拉嗪治疗而使用生物治疗不会增加不良结局的风险 , objectType=article, longId=193333, objectId=f6af19333361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6af19333361, replyNumber=0, likeNumber=42, createdTime=2020-08-27, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6af19333361, moduleTitle=Clin Gastroenterology H：在克罗恩病患者中停止美沙拉嗪治疗而使用生物治疗不会增加不良结局的风险 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6af19333361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702861, encodeId=50f51e0286150, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物, objectType=article, longId=157175, objectId=d85415e175ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85415e175ac, replyNumber=0, likeNumber=39, createdTime=2019-09-23, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85415e175ac, moduleTitle=Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85415e175ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702862, encodeId=396b1e02862ec, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Teva宣布在美国推出Delzicol（美沙拉嗪）延迟释放胶囊仿制药, objectType=article, longId=165918, objectId=9a23165918db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a23165918db, replyNumber=0, likeNumber=34, createdTime=2019-10-28, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a23165918db, moduleTitle=Teva宣布在美国推出Delzicol（美沙拉嗪）延迟释放胶囊仿制药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a23165918db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702860, encodeId=25731e0286084, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Gastroenterology：布地奈德与美沙拉嗪或安慰剂作为淋巴细胞性结肠炎的诱导治疗的疗效和安全性分析, objectType=article, longId=155495, objectId=0df4155495c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0df4155495c9, replyNumber=0, likeNumber=23, createdTime=2019-05-09, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0df4155495c9, moduleTitle=Gastroenterology：布地奈德与美沙拉嗪或安慰剂作为淋巴细胞性结肠炎的诱导治疗的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0df4155495c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702859, encodeId=00371e02859f2, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=AP&T：美沙拉嗪在溃疡性结肠炎中的安全性分析, objectType=article, longId=139465, objectId=6e6913946513, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e6913946513, replyNumber=0, likeNumber=26, createdTime=2018-10-10, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e6913946513, moduleTitle=AP&T：美沙拉嗪在溃疡性结肠炎中的安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e6913946513)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702858, encodeId=e77c1e02858a5, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=Aliment Pharmacol Ther：美沙拉嗪预防憩室炎复发并无优势！, objectType=article, longId=107043, objectId=589f10e043fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=589f10e043fe, replyNumber=0, likeNumber=28, createdTime=2017-11-13, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=589f10e043fe, moduleTitle=Aliment Pharmacol Ther：美沙拉嗪预防憩室炎复发并无优势！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=589f10e043fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702857, encodeId=84f61e0285786, content=<a href='/topic/show?id=ea9ae99666e' target=_blank style='color:#2F92EE;'>#美沙拉嗪#</a>, objectTitle=AP&T：美沙拉嗪栓剂对溃疡型结肠炎安全有效, objectType=article, longId=22699, objectId=366f2269953, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=366f2269953, replyNumber=0, likeNumber=34, createdTime=2013-12-20, rootId=0, userName=zhangyxzsh, userId=bf3e30418720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=366f2269953, moduleTitle=AP&T：美沙拉嗪栓剂对溃疡型结肠炎安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=366f2269953)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#梭菌# #山梨醇# #粪厌氧棒杆菌# #美沙拉嗪#

2024-02-26发表于上海

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

Clin Gastroenterology H：在克罗恩病患者中停止美沙拉嗪治疗而使用生物治疗不会增加不良结局的风险

2020-08-27

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

Inflam Bowel Dis：miR-206可以作为溃疡性结肠炎对美沙拉嗪治疗反应的生物标志物

2019-09-23

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

Teva宣布在美国推出Delzicol（美沙拉嗪）延迟释放胶囊仿制药

2019-10-28

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

Gastroenterology：布地奈德与美沙拉嗪或安慰剂作为淋巴细胞性结肠炎的诱导治疗的疗效和安全性分析

2019-05-09

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

AP&T：美沙拉嗪在溃疡性结肠炎中的安全性分析

2018-10-10

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

Aliment Pharmacol Ther：美沙拉嗪预防憩室炎复发并无优势！

2017-11-13

zhangyxzsh (审核中...)

前往app查看评论内容

#美沙拉嗪#

AP&T：美沙拉嗪栓剂对溃疡型结肠炎安全有效

2013-12-20

科室
- - 订阅+
  - 更多科室
工具
服务